Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > KWS love your stuff but 13 billion takeout price in 2022?
View:
Post by HCallahann44 on Nov 08, 2021 7:50pm

KWS love your stuff but 13 billion takeout price in 2022?

No way is that happening....the price wouldn't be stuck in the 2s if that was going to happen....I love your fantastical predictions but they are very much disconnected from reality. I would not be surprised if we were sitting at 2 next year this time....
Comment by askretka on Nov 12, 2021 8:25am
While a 13 billion takeout of Oncolytics is possible I think its unlikely but if you look at market size and demographic trends I can see where he's getting numbers from. Currently oncology market worldwide is about 230 billion. Increasing to over 600 billion by 2030. Current breast cancer market worldwide is about 20 billion a year. 50 billion predicted by 2030. There new immunotherapies need ...more  
Comment by fox7mf on Nov 12, 2021 11:21am
I'm in agreement with KWS...$13b or in that neighborhood. Hey, the science is sound & groundbreaking...plus these guys owe us at least that for our otherworldly patience!!;)
Oncolytics Biotech Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities